Kinetin

Kinetin

SCHEMBL15705

c1coc(CNc2ncnc3[nH]cnc23)c1

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 11/20 0.66
TSHR P16473 5/20 0.66
MEN1 O00255 3/20 0.66
KMT2A Q03164 3/20 0.66
HIF1A Q16665 2/20 0.66
ALOX15 P16050 2/20 0.66
CYP1A2 P05177 2/20 0.66
TP53 P04637 1/20 0.66
ADORA3 P0DMS8 1/20 0.66
KDR P35968 1/20 0.66
POLB P06746 3/20 0.59
CCNB2 O95067 2/20 0.56
CDK1 P06493 2/20 0.56
CCNB1 P14635 2/20 0.56
CCNB3 Q8WWL7 2/20 0.56
HTT P42858 8/20 0.54
RAB9A P51151 1/20 0.54
LMNA P02545 6/20 0.52
MAPK1 P28482 6/20 0.52
AURKA O14965 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kinetin SCHEMBL29829493 1.00 SMN1; SMN2 (0.66) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL19064637 0.88 SMN1; SMN2 (0.51) SMN1; SMN2TSHRMEN1KMT2AHIF1A
Kinetin SCHEMBL17847289 0.88 SMN1; SMN2 (0.53) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL17009422 0.85 SMN1; SMN2 (0.49) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL16146105 0.83 SMN1; SMN2 (0.52) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL17009421 0.82 SMN1; SMN2 (0.44) SMN1; SMN2TSHRMEN1KMT2AHIF1A
6-Benzylaminopurine SCHEMBL6864326 0.82 SMN1; SMN2 (0.47) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL20119562 0.81 SMN1; SMN2 (0.50) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL29829331 0.81 SMN1; SMN2 (0.55) SMN1; SMN2TSHRMEN1KMT2AHIF1A
SCHEMBL19064636 0.81 SMN1; SMN2 (0.55) SMN1; SMN2TSHRMEN1KMT2AHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250185662-A1 COMPOSITION FOR ENHANCING PLANT GROWTH CH BIOTECH R&D CO., LTD. (TW) 2025-06-12 US claimed
CN-119949324-A Seed coating agent for resisting low-temperature phytotoxicity 沈阳中化农药化工研发有限公司 2025-05-09 CN claimed
US-20250143245-A1 COMPOSITIONS AND METHODS RELATED TO SOMATIC EMBRYOGENESIS IN ROSE PLANTS NORTH CAROLINA STATE UNIVERSITY 2025-05-08 US claimed
WO-2025085914-A1 COMPOSITIONS AND METHODS FOR MITIGATING THE EFFECTS OF VIROID INFECTION IN PLANTS DEYLE LUCAS GEOFFREY (US) 2025-04-24 WO claimed
CN-119836946-A Method for improving survival rate of bud grafting of big rubber tree 云南省热带作物科学研究所 2025-04-18 CN claimed
CN-119184102-A Plant regulator for inhibiting thin pulp and acerbity of litchi, preparation method and application thereof 中锦集团(海南)有限公司 2024-12-27 CN claimed
CN-118995562-A Novel method for separating and fusing mulberry protoplast 山东中医药大学 2024-11-22 CN claimed
EP-4447648-A1 PAEONIA DEDIFFERENTIATED PLANT CELLS OF THE GENUS, EXTRACTS THEREOF AND COSMETIC USES THEREOF L'OREAL (FR) 2024-10-23 EP claimed
WO-2024197373-A1 PROCESS FOR OBTAINING PLANT EMBRYOGENIC CALLI, FOR OBTAINING PLANT SOMATIC EMBRYOS, FOR OBTAINING SEEDLINGS, FOR PRODUCING SYNTHETIC SEED, FOR GENETIC MODIFICATION, AND SYNTHETIC SEED CTC - CENTRO DE TECNOLOGIA CANAVIEIRA S.A. (BR) 2024-10-03 WO claimed
CN-118476474-A Cultivation method of radix asparagi 北京蓝标一成科技有限公司 2024-08-13 CN claimed
WO-1997020034-A9 AUXINIC ANALOGUES OF INDOLE-3-ACETIC ACID 1997-10-16 WO claimed
EP-0799327-A1 PROCESS FOR THE CORROSION PROTECTION OF COPPER OR COPPER ALLOYS COOKSON GROUP plc (GB) 1997-10-08 EP claimed
US-5674731-A AN AUXIN PLANT GROWTH INTENSIFIERS LIFE TECHNOLOGIES, INC. (US) 1997-10-07 US claimed
WO-1997020034-A1 AUXINIC ANALOGUES OF INDOLE-3-ACETIC ACID LIFE TECHNOLOGIES, INC. (US) 1997-06-05 WO claimed
WO-1996034089-A1 REGENERATION OF BOTH PLANT TISSUES AND TRANSGENIC PLANT TISSUES USING A NEW PLANT HORMONE, 5-BROMOINDOLE-3-ACETIC ACID LIFE TECHNOLOGIES, INC. (US) 1996-10-31 WO claimed
WO-1996020295-A1 PROCESS FOR THE CORROSION PROTECTION OF COPPER OR COPPER ALLOYS COOKSON GROUP PLC (GB) 1996-07-04 WO claimed
EP-0696166-A1 COMPOSITION FOR TREATMENT OF PLANT MATERIAL Carstairs, Margaret Louise (GB) 1996-02-14 EP claimed
WO-1994024856-A1 COMPOSITION FOR TREATMENT OF PLANT MATERIAL BRITISH TECHNOLOGY GROUP LIMITED (GB) 1994-11-10 WO claimed
US-4169717-A METAL PROTEINATE AND GROWTH HORMONE ASHMEAD H H 1979-10-02 US claimed
US-4003156-A Process for obtaining variants of plants with improved characteristics AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) 1977-01-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250185662-A1 COMPOSITION FOR ENHANCING PLANT GROWTH CHAT, CBS, CHKA SMN1; SMN2 4881/4885TSHR 1964/4885MEN1 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.